02 Oct 2023 by admin in UncategorizedComments Syros Announces Planned CEO Leadership Transition and Strategic Reorganization to Support Long-Term Business Growth and Maturation into a Commercial Biopharmaceutical Company
19 Sep 2023 by admin in UncategorizedComments Tempest Announces Expanded Role for Sam Whiting, M.D., Ph.D., as Chief Medical Officer and Head of Research and Development
12 Sep 2023 by admin in UncategorizedComments Kira Pharmaceuticals Presents Complete Data from Phase 1 SYNERGY-1 Trial of KP104 and Preclinical Studies in Autoimmune Skin Disease Models from Collaboration with University of Lübeck at the 29th International Complement Workshop (ICW 2023)
07 Sep 2023 by admin in UncategorizedComments NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
05 Sep 2023 by admin in UncategorizedComments Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb
04 Sep 2023 by admin in UncategorizedComments Crescendo Biologics Wins Significant European Patent Office Ruling Related to the Engineering of Immunoglobulin Therapeutics
18 Aug 2023 by admin in UncategorizedComments Eluminex Biosciences Completes Series B+ Financing, Raising More Than $50 M in 2023
14 Aug 2023 by admin in UncategorizedComments Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia
10 Aug 2023 by admin in UncategorizedComments Oricell OriCAR-017 CAR-T Therapy Clears IND Hurdle, Paving the Way for Global Impact
24 Jul 2023 by admin in UncategorizedComments Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours
17 Jul 2023 by admin in UncategorizedComments Alebund Achieved First Patient Enrolment for AP301 Pivotal Phase 3 Clinical Trial and Successfully Held Investigator Meeting in Beijing
11 Jul 2023 by admin in UncategorizedComments Adicet Announces Appointment of Katie Peng to the Board of Directors
16 May 2023 by admin in UncategorizedComments Eluminex Biosciences Receives Scientific Recognition for its Recombinant Human Collagen (rhCIII) Biosynthetic Cornea (EB- 301) Program to Treat Corneal Blindness
09 May 2023 by admin in UncategorizedComments Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
27 Apr 2023 by admin in UncategorizedComments Crescendo Biologics appoints Angus Hone as Chief Financial Officer
12 Apr 2023 by admin in UncategorizedComments Alebund Pharmaceuticals Closes Nearly RMB 200 Million Pre-C Round Financing and Secures RMB 800 Million Syndicated Loan Credit
17 Mar 2023 by admin in UncategorizedComments China’s NMPA Clears Phase 3 IND Application for Alebund Pharmaceutical’s AP301, a New-generation Iron-based Phosphate Binder, to Treat Hyperphosphatemia in Dialysis Patients
28 Feb 2023 by admin in UncategorizedComments Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
28 Feb 2023 by admin in UncategorizedComments Eluminex Biosciences Closes $40+ Million Series B Financing
14 Feb 2023 by admin in UncategorizedComments Eluminex Announces Completion of Enrollment in Part A of the CLARITY Study
31 Jan 2023 by admin in UncategorizedComments Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR- 017 in the Treatment of RRMM
31 Jan 2023 by admin in UncategorizedComments Crescendo Biologics is category winner for Biopharma and Vaccines in 2023 UK DIT Life Sciences Innovator Showcase
26 Jan 2023 by admin in UncategorizedComments Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome
20 Dec 2022 by admin in UncategorizedComments Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia
09 Dec 2022 by admin in UncategorizedComments Arcellx And Kite Announce Strategic Collaboration To Co- Develop And Co-Commercialize Late-Stage Clinical CART- DdBCMA In Multiple Myeloma
02 Dec 2022 by admin in UncategorizedComments INNOFORCE OPENS GMP MANUFACTURING FACILITY & CORPORATE HEADQUARTERS IN HANGZHOU, CHINA TO PROVIDE CDMO SERVICES FOR GLOBAL SUPPLY OF RNA, CELL & GENE THERAPIES
30 Nov 2022 by admin in UncategorizedComments Kira Pharmaceuticals Announces First Cohort of Patients Dosed
30 Nov 2022 by admin in UncategorizedComments Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer
17 Nov 2022 by admin in UncategorizedComments Laronde Appoints Pablo J. Cagnoni as Chief Executive Officer
15 Nov 2022 by admin in UncategorizedComments NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates
14 Nov 2022 by admin in UncategorizedComments Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
14 Nov 2022 by admin in UncategorizedComments Arcellx Reports Third Quarter 2022 Financial Results And Business Progress
08 Nov 2022 by admin in UncategorizedComments Tempest Reports Third Quarter 2022 Financial Results and Provides Business Update
